Literature DB >> 15513550

A daily nasal spray with saline prevents symptoms of rhinitis.

Liselott Tano1, Krister Tano.   

Abstract

OBJECTIVE: To ascertain whether a daily nasal spray with physiological saline could prevent symptoms of common cold in a population of otherwise healthy adults.
MATERIAL AND METHODS: This was study involving 10 weeks of daily use of a nasal saline spray and 10 weeks of only recording symptoms. Young adults eligible for military service at an army barrack in Boden, Sweden were invited to participate in the study and 108 healthy conscripts aged approximately 20 years agreed to do so. Data were recorded by the participants in a diary at home. In the diary the participants noted symptoms such as rhinitis, blocked nose, cough, fever and sore throat (pharyngeal pain). They also recorded inability to perform their duties due to the symptoms, and any medication or antibiotics necessitated by upper respiratory tract infection.
RESULTS: A total of 69 subjects completed the 20-week diary period. For 60 of them, compliance during the spray period exceeded 60% and their data were used in the statistical calculations. During the spray period the number of days with nasal secretion and/or blocked nose (mean 6.4 days) was significantly (p=0.027) lower than that during the observation period (mean 11 days). Furthermore, the participants had a mean of 0.7 episodes of upper respiratory tract infection during the spray period, compared with 1.0 episodes during the observation period (p=0.05).
CONCLUSION: A daily nasal spray with saline can prevent nasal symptoms of common cold in a population of otherwise healthy adults.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15513550     DOI: 10.1080/00016480410017657

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  18 in total

1.  Nasal Irrigation as Treatment in Sinonasal Symptoms Relief: A Review of Its Efficacy and Clinical Applications.

Authors:  Baharudin Abdullah; Chenthilnathan Periasamy; Rushdan Ismail
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2017-01-13

2.  Management of upper respiratory tract infections in children.

Authors:  Mf Cotton; S Innes; H Jaspan; A Madide; H Rabie
Journal:  S Afr Fam Pract (2004)       Date:  2008-03

Review 3.  Nasal irrigation as an adjunctive treatment in allergic rhinitis: a systematic review and meta-analysis.

Authors:  Kristina E Hermelingmeier; Rainer K Weber; Martin Hellmich; Christine P Heubach; Ralph Mösges
Journal:  Am J Rhinol Allergy       Date:  2012 Sep-Oct       Impact factor: 2.467

Review 4.  Saline nasal irrigation for upper respiratory conditions.

Authors:  David Rabago; Aleksandra Zgierska
Journal:  Am Fam Physician       Date:  2009-11-15       Impact factor: 3.292

Review 5.  Nasal saline irrigations for the symptoms of acute and chronic rhinosinusitis.

Authors:  Nils Achilles; Ralph Mösges
Journal:  Curr Allergy Asthma Rep       Date:  2013-04       Impact factor: 4.806

6.  Nasal irrigation for chronic sinus symptoms in patients with allergic rhinitis, asthma, and nasal polyposis: a hypothesis generating study.

Authors:  David Rabago; Emily Guerard; Don Bukstein
Journal:  WMJ       Date:  2008-04

7.  The prescribing patterns of Wisconsin family physicians surrounding saline nasal irrigation for upper respiratory conditions.

Authors:  David Rabago; Aleksandra Zgierska; Paul Peppard; Amy Bamber
Journal:  WMJ       Date:  2009-05

Review 8.  A review on the therapeutic effects of NetiKriya with special reference to JalaNeti.

Authors:  S Meera; M Vandana Rani; Cijith Sreedhar; Delvin T Robin
Journal:  J Ayurveda Integr Med       Date:  2019-01-05

9.  Could nasal irrigation and oral rinse reduce the risk for COVID-19 infection?

Authors:  Manuele Casale; Vittorio Rinaldi; Lorenzo Sabatino; Antonio Moffa; Massimo Ciccozzi
Journal:  Int J Immunopathol Pharmacol       Date:  2020 Jan-Dec       Impact factor: 3.219

10.  Prophylactic administration of bacterially derived immunomodulators improves the outcome of influenza virus infection in a murine model.

Authors:  Elizabeth B Norton; John D Clements; Thomas G Voss; Lucia Cárdenas-Freytag
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.